PDE3A and hypertensive disorder: A recent study shows that the hypertension-related gain-of-function mutations of PDE3A do not affect overall adrenergic stimulation and cAMP levels but reduce PLB phosphorylation, which leads to adaptive change in Ca2+ cycling and protects against hypertension-induced cardiac damage in the hearts (230).